FDA Limits J&J COVID-19 Vaccine

The FDA yesterday set limits on Johnson & Johnson’s Covid-19 vaccine because of the risk of a clotting disorder discovered weeks after the vaccine was first put into use in spring 2021. The agency said its review of the available data on the risk of thrombosis with thrombocytopenia — or TTS — suggested limiting access to the vaccine is warranted. The condition, though rare, can be fatal. The single-dose vaccine will now be available only to adults 18 and older who would not otherwise agree to be vaccinated or who cannot take one of the other available vaccines for medical Read More …

Community Health Worker Program

The ICD is engaged in the Delaware Academy of Medicine/Delaware Public Health Association’s COVID-19 Community Health Worker (CHW) Initiative. This initiative aims to address persistent health disparities and vaccine hesitancy in Pennsylvania and Delaware by offering support and resources to vulnerable and under-resourced populations, and to newly identified populations eligible to receive the COVID-19 vaccine. Read more

Adolescent Immunization Action Week

Adolescent Immunization Action Week is here (April 4-8)! AIM is partnering with Unity Consortium to spread the word about the importance of adolescent immunization vaccination. This toolkit provides a video, messaging, webinar registration, graphics, and more to help raise awareness for this important cause. 

DJPH: Vaccine Preventable Disease

The latest issue of the Delaware Journal of Public Health focuses on Vaccine Preventable Disease. Guest Editors Omar Khan, MD, MHS and Stephen Eppes, MD have curated content about current vaccine recommendations, travel vaccines, vaccines specific to certain viruses, vaccine hesitancy, and vaccination exemptions.  The journal is open-source, and free to all.  Check it out here

2022-2023 Flu Vaccine Composition

February 25, 2022.  The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2022-2023 influenza season in the northern hemisphere. The announcement was made at an information session at the end of a 4-day Information Meeting on the Composition of Influenza Virus Vaccines, a meeting that is held twice annually. The WHO recommends that quadrivalent vaccines for use in the 2022-2023 influenza season in the northern hemisphere contain the following:   Egg-based vaccines an A/Victoria/2570/2019 (H1N1)pdm09-like virus; an A/Darwin/9/2021 (H3N2)-like virus; a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Cell Read More …

MOTIVATE Project

The Motivating Older Adults to Trust Information About Vaccines and Their Effects (MOTIVATE) project is a partnership between Center in the Park and Rutgers University that focuses on vaccine hesitancy among older adults. Led by peer leaders and pharmacists, it addresses vaccine education for COVID-19, Pneumonia, and Flu. This two session project will be conducted via zoom and participants will receive a $10 Visa gift card for participation. For more information, contact Keyerra Charles, Director of Health Promotion at 215-848-7722 Ext 305 or email kcharles@centerinthepark.org